×

Growth Reports

Growth Reports
Report Name

Gel Electrophoresis Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Classification, Agarose Gel, Pulse Field Gel, Temperature Gradient Gel), By Application (Laboratory Research, Pharmaceutical, Biotechnological Companies), By Technique (Gel Electrophoresis, Capillary Electrophoresis), Countries and Companies Report

Gel Electrophoresis Market is projected to register a 5.3% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022213  |   No. of Pages: 192

Gastroscopes Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Standard Gastroscopes, Therapeutic Gastroscopes, Dual Channel Gastroscopes, Transnasal Gastroscopes), By Application (Gastric Ulcers, Chronic Gastritis, Normal Mucosa, Others), By End-User (Hospitals and Clinical Labs, Diagnostic Laboratories, Ambulatory Surgical Centers), Countries and Companies Report

Gastroscopes Market is projected to register a 6.3% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022211  |   No. of Pages: 199

Gastroparesis Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Class (Antiemetic Agents, Prokinetic Agents, Botulinum Toxin Injections), By Disease (Diabetic Gastroparesis, Post-Surgical Gastroparesis, Idiopathic Gastroparesis, Others), By End-User (Hospitals, Clinics, Pharmacies), Countries and Companies Report

Gastroparesis Drugs Market is projected to register a 4.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022210  |   No. of Pages: 205

Gastrointestinal Stromal Tumor (GIST) Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug (Imatinib, Ripretinib, Crenolanib, Regorafenib, Avapritinib, Sunitinib, Entrectinib, Larotrectinib), By Therapy (Targeted therapy, Chemotherapy, Radiation therapy ), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), By Route of Administration (Oral, Parenteral), Countries and Companies Report

Gastrointestinal Stromal Tumor (GIST) Therapeutics Market is projected to register a 6.4% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022209  |   No. of Pages: 203

Gastrointestinal (GI) Diseases Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Class (Anti-inflammatory and immunosuppressors, Acid neutralizers, Others), By Type (Branded, Generics), Countries and Companies Report

Gastrointestinal (GI) Diseases Therapeutics Market is projected to register a 5.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022208  |   No. of Pages: 204

Gastrointestinal Bleeding Treatment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Endoscopic Mechanical Devices, Endoscopic Thermal Devices, Others), By GI Tract Division (Upper GI Tract, Lower GI Tract), By End-User (Hospitals/Clinics, Ambulatory Surgical Centres, Others), Countries and Companies Report

Gastrointestinal Bleeding Treatment Market is projected to register a 4.3% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022207  |   No. of Pages: 190

Gastroesophageal Reflux Disease (GERD) Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Diagnosis (Upper Endoscopy, Ambulatory Acid (pH) Probe Test, Esophageal Manometry, Others), By Drug (Proton Pump Inhibitors (PPIs), H2 Receptor Blockers, Others), Countries and Companies Report

Gastroesophageal Reflux Disease (GERD) Market is projected to register a 4.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022206  |   No. of Pages: 204

Gastric Cancer Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Class (PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists, Others) ), By Route of Administration (Injectable, Oral), By Distribution Channel (Offline, Online), Countries and Companies Report

Gastric Cancer Drugs Market is projected to register a 14.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022205  |   No. of Pages: 201

Gastric Band Devices Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Adjustable Gastric Bands, Non-Adjustable Gastric Bands), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Obesity Centers), Countries and Companies Report

Gastric Band Devices Market is projected to register a 4.9% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022204  |   No. of Pages: 190